Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Department of Critical Care Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
Regional Medical Center for National Institute of Respiratory Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, China.
J Glob Antimicrob Resist. 2021 Jun;25:26-34. doi: 10.1016/j.jgar.2021.02.020. Epub 2021 Mar 2.
Hypervirulence and carbapenem resistance have emerged as two distinct evolutionary directions for Klebsiella pneumoniae, which pose a great threat in clinical settings. Multiple virulence factors contribute to hypervirulence, and the mechanisms of carbapenem resistance are complicated. However, more and more K. pneumoniae strains have been identified in recent years integrating both phenotypes, resulting in devastating clinical outcomes. Hypervirulent and carbapenem-resistant K. pneumoniae (CR-hvKP) emerged in the early 2010s and thereafter have become increasingly prevalent. CR-hvKP are primarily prevalent in Asia, especially China, but are reported all over the world. Mechanisms for the emergence of CR-hvKP can be summarised by three patterns: (i) carbapenem-resistant K. pneumoniae (CRKP) acquiring a hypervirulent phenotype; (ii) hypervirulent K. pneumoniae (hvKP) acquiring a carbapenem-resistant phenotype; and (iii) K. pneumoniae acquiring both a carbapenem resistance and hypervirulence hybrid plasmid. With their global dissemination, continued surveillance of the emergence of CR-hvKP should be more highly prioritised.
产超广谱β-内酰胺酶和碳青霉烯类耐药的肺炎克雷伯菌已经成为临床上的两大威胁,分别朝着高毒力和耐碳青霉烯类的两个不同进化方向发展。产超广谱β-内酰胺酶肺炎克雷伯菌的高毒力是由多种毒力因子决定的,而耐碳青霉烯类肺炎克雷伯菌的耐药机制较为复杂。但近年来,越来越多的产超广谱β-内酰胺酶和碳青霉烯类耐药肺炎克雷伯菌(CR-hvKP)被发现,其临床表现较为严重。产超广谱β-内酰胺酶和碳青霉烯类耐药肺炎克雷伯菌(CR-hvKP)于 21 世纪 10 年代初出现,此后便日益流行。CR-hvKP 主要流行于亚洲,尤其是中国,但世界各地均有报道。CR-hvKP 产生的机制可归纳为以下三种模式:(i)耐碳青霉烯类肺炎克雷伯菌(CRKP)获得高毒力表型;(ii)高毒力肺炎克雷伯菌(hvKP)获得耐碳青霉烯类表型;(iii)肺炎克雷伯菌获得耐碳青霉烯类和产超广谱β-内酰胺酶的混合质粒。随着它们在全球的传播,应该更加重视对 CR-hvKP 出现的持续监测。